HIGHLIGHTS
- What: In the study , two 7-year periods (2005-2011 and 2012-2018) were compared, with 51 patients diagnosed with AILDs in the first period and 69 in the second period. In the study , the relapse rate was determined to be 48.5%.
- Who: Buğra Kaan Bahçeci from the Depertmant of Internal Medicine, Hopa State Hospital, Artvin, Turkey Ondokuz Mayıs University, Samsun, Turkey have published the research: Changing epidemiology and treatment responses in autoimmune liver diseases: a 14-year retrospective analysis from a tertiary care center, in the Journal: (JOURNAL)
-

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.